Biosimilars Asia Summit

The Biosimilars Market in Asia represents a significant opportunity, and is gaining momentum and prominence as the patents of big branded drugs lapse .. Read more and cost-cutting initiatives are implemented in the healthcare sector. Asia is poised to position itself as the centre for global biosimilars manufacturing, development and adoption. This year in 2021, come 18-19 May 2021, we will gather leading industry experts to track progress and updates in the market, whilst providing experiences on how to tackle your biggest concerns and challenges when it comes to biosimilars! gather leading industry experts to track progress and updates in the market, whilst providing experiences on how to tackle your biggest concerns and challenges when it comes to biosimilars! However there are several challenges and barriers to the growth which include concerns about the drug safety and efficacy of biosimilars, lack of knowledge on tackling challenges in the manufacturing, clinical development and adoption of biosimilars, commercialisation and market penetration strategies, regulatory concerns and issues concerning interchangeability, substitution and nomenclature.